Hashimoto's thyroiditis and papillary thyroid carcinoma: Is there a correlation?

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 2, 2013, Pages 474-482

  Jankovic, Bojana ^a,b   Le, Karen T ^a,b   Hershman, Jerome M ^b,c,d  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN PATCHED 1; PROTEIN RET;

AKT GENE; CANCER RISK; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FINE NEEDLE ASPIRATION BIOPSY; GENE REARRANGEMENT; GENETIC LINKAGE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; PI3K GENE; PREVALENCE; PRIORITY JOURNAL; PTC GENE; RET GENE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; THYROID CARCINOMA; THYROIDECTOMY; TUMOR GENE; COMORBIDITY; PAPILLARY CARCINOMA; PATHOLOGY; THYROID TUMOR;

CARCINOMA, PAPILLARY; COMORBIDITY; HASHIMOTO DISEASE; HUMANS; PREVALENCE; THYROID NEOPLASMS;

MLCS; MLOWN;

EID: 84873662351     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2978     Document Type: Review

References (44)

1. Mazakopakis E, Tzortzinis A, Dalieraki-Ott E, et al. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study. Hormones (Athens). 2010;9:312-318.
2. Cipolla C, Sandonato L, Graceffa G, et al. Hashimoto thyroiditis coexistent with papillary carcinoma. Am Surg. 2005;71:874-878.
3. Anderson L, Middleton WD, Teefey SA, et al. Hashimoto thyroiditis. Part 2: sonographic analysis of benign and malignant nodules in patients with diffuse Hashimoto thyroiditis. Am J Roentgenol. 2010;195:216-222.
4. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-2167.
5. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.
6. Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. Arch Surg. 1955;70:291-297.
7. Crile GJ, Hazard JB. Incidence of cancer in struma lymphomatosa. Surg Gynecol Obstet. 1962;115:101-103.
8. Crile GJ. Struma lymphomatosa and carcinoma of the thyroid. Surg Gynecol Obstet. 1978;147:350-352.
9. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. NEngl J Med. 1985;312:601-604.
10. Carson H, Castelli M, Gattuso P. Incidence of neoplasia in Hashimoto's thyroiditis: a fine-needle aspiration study. Diagn Cytopathol. 1996;14:38-42.
11. Erdogan M, Erdem N, Cetinkalp S, et al. Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto's thyroiditis: a result of a university hospital of 769 patients in Turkey. Endocrine. 2009;36:486-490.
12. Matesa-Anić D, Matesa N, Dabelić N, Kusić Z. Coexistence of papillary carcinoma and Hashimoto's thyroiditis. Acta Clin Croat. 2009;48:9-12.
13. Anil C, Goksel S, Gursoy A. Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid. 2010;20:601-606.
14. Mukasa K, Noh JY, Kunii Y, et al. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid disease. Thyroid. 2011;21: 37-41.
15. Boi F, Lai ML, Minerba L, Faa G, Mariotti S. High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol. 2005;153:637-642.
16. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact of presentation, management and outcome. Surgery. 1999; 126:1070-1077.
17. Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer. J Surg Res. 2008;150:49-52.
18. Larson SD, Jackson L, Riall T, et al. Increased incidence of welldifferentiated thyroid cancer associated with Hashimoto's thyroid-itis and the role of the PI3K/AKT pathway. J Am Coll Surg. 2007; 204:764-775.
19. Kurukahvecioglu O, Taneri F, Yuksel O, Aydin A, Tezel E, Onuk E. Total thyroidectomy for treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma. Adv Ther. 2007;24:510-516.
20. Bradly D, Reddy V, Prinz RA, Gattuso P. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery. 2009;146:1099-1104.
21. Siriweera EH, Ratnatung NV. Profile of Hashimoto's thyroiditis in Sri Lankans: is there an increased risk of ancillary pathologies in Hashimoto's thyroiditis. J Thyroid Res. 2010;2010:1-5.
22. Tamimi D. The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol. 2002;10:141-146.
23. Kebebew E, Treseler P, Ituarte P, Clark O. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg. 2001;25:632-637.
24. Consorti F, Loponte M, Milazzo F, Potasso L, Antonaci A. 2101 Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto's thyroiditis. Eur Surg Res. 45:333-337.
25. D'Avanzo B, Vecchia CL, Franceschi S, Negri E, Talamini R. History of thyroid diseases and subsequent thyroid cancer risk. Cancer Epidemiol Biomarkers Prev. 1995;4:193-199.
26. Yoon YH, Kim HJ, Lee JW, Kim JM, Koo BS. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinoloaryngol. 2012;269:1013-1017.
27. Okayasu I, Fujiwara M, Kara Y, Tanaka Y, Rose NR. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. Cancer. 1995;76:2312-2318.
28. Ott RA, Calandra DB, McCall A, Shah KH, Lawrence AM, Paloyan E. The incidence of thyroid carcinoma in patients with Hashimoto's thyroiditis and solitary cold nodules. Surgery. 1985;98:1202-1206.
29. Buyukasik O, Hasdemir AO, Yalcin E, et al. The association between thyroid malignancy and chronic lymphocytic thyroiditis: should it alter the surgical approach. Endokrynol Pol. 2011;62: 303-308.
30. Anderson C, Graham C, Herriot M, Kamel H, Salter D. CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto's thyroiditis. Histopathology. 2009;55:683-686.
31. Mechler C, Bounacer A, Suarez H, et al. Papillary thyroid carcinoma: 6 cases from 2 families with associated lympocytic thyroiditis harbouring RET/PTC rearrangements. Br J Cancer. 2001;85:1831-1837.
32. Muzza M, Degl'innocenti DD, Colombo C, et al. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf). 2010;72:702-708.
33. Royer MC, Zhang H, Fan CY, Kokoska MS. Genetic alterations in papillary thyroid carcinoma and Hashimoto thyroiditis. Arch Otolaryngol Head Neck Surg. 2010;136:240-242.
34. Nguyen GK, Ginsberg J, Crockford PM, Villanueva RR. Hashimoto's thyroiditis: cytodiagnostic accuracy and pitfalls. Diagn Cytopathol. 1997;16:531-536.
35. Ravinsky E, Safneck JR. Differentiation of Hashimoto's thyroiditis from thyroid neoplasms in fine needle aspirates. Acta Cytol. 1988; 32:854-861.
36. Kumarasinghe MP, De Silva S. Pitfalls in cytological diagnosis of autoimmune thyroiditis. Pathology. 1999;31:1-7.
37. MacDonald L, Yazdi HM. Fine needle aspiration biopsy of Hashimoto's thyroiditis. Sources of diagnostic error. Acta Cytol. 1999;43:400-406.
38. Seifman M, Grodski S, Bailey M, Yeung M, Serpell J. Surgery in the setting of Hashimoto's thyroiditis. ANZ J Surg. 2011;81:519-523.
39. Eisenberg BL, Hensley SD. Thyroid cancer with coexistent Hashimoto's thyroiditis. Clinical assessment and management. Arch Surg. 1989;124:1045-1047.
40. Kim EY, Kim WG, Kim WB, et al. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2009;71: 581-586.
41. McLeod DS, Watters KF, Carpenter AD, Ladenson PW, Cooper DS, Ding EL. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J Clin Endocrinol Metab. 2012;97:2682-2692.
42. Wirtschafter A, Schmidt R, Rosen D, et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope. 1997;107:95-100.
43. Unger P, Ewart M, Wang B, Gan L, Kohtz S, Burstein D. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathological link? Hum Pathol. 2003;34:764-769.
44. Burstein D, Chandandeep N, Wang B, Unger P. Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and Hashimoto's thyroiditis: a stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol. 2004;35:465-473.